Search
Magnetoencephalography Core: Core Facilities - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/core-facilities/meg-core/
The Magnetoencephalography (MEG) Center of Excellence features a state-of-the-art MEGIN Triux-Neo whole-head MEG system.
Scanning Electron Microscopy (SEM): Electron Microscopy Core Facility - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/core-facilities/emcf/equipment/sem.html
The Electron Microscopy Core Facility (EMCF) offers TEM of cells & tissues, negative staining, whole-mount SEM, correlative LM and EM, and Immunogold labeling.
CMRU Core Offerings: Biorepository: Research Cores - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/core-facilities/cardiometabolic-research-unit/offerings/biorepository.html
Biorepository: Multi-Specimen Biobank Access Our biorepository provides access to a diverse collection of biological specimens, including blood, plasma, serum, and tissue samples. This multi-specimen biobank supports a wide range of research projects, ensuring the availability of high-quality samples for future studies. Our extensive biorepository offers numerous advantages for clinical research. It enhances research capabilities by providing a diverse array of biological samples, which are
Metabolic Phenotyping Core Facility – UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/core-facilities/mouse-metabolic-phenotyping/
The Metabolic Phenotyping Core provides state-of-the-art analytical and phenotypical measures to the scientific community inside and outside of UT Southwestern.
Next Generation Sequencing Core Facility - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/core-facilities/next-generation-sequencing/
State-of-the-art sequencing facility that performs NGS coupled to bioinformatic analysis
Community Engagement: CTSA - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/ctsa/community-engagement/
UTSW offers resources and opportunities for both researchers and community members to participate in research that leads to sustained collaboration across groups and greater health equity.
Investigator Impact - UTSW Kidney Cancer Program
https://kcp.utsw.edu/research/investigator-impacts/
Home About Us Mission Fact Sheet Highlights KCP Report Community Leadership Staff Our Experts Kidney Cancer Experts Collaborating Physicians Research SPORE Award Investigator Impact Advisory Board Patient Resources Overview Clinical Trials Community Support Advocacy Newsroom News Videos Support Us Donate Patient Tributes Connect Facebook-f Twitter Youtube Envelope Linkedin Home About Us Mission Fact Sheet Highlights KCP Report Community Leadership Staff Our Experts Kidney Cancer Experts
Pricing: Metabolomics Core Facility - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/core-facilities/metabolomics/services/pricing.html
Review pricing information for the Metabolomics Core Facility.
Cytochrome P450 Inhibition: Preclinical Pharmacology Lab - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/research/core-facilities/preclinical-pharmacology/pricing-and-services/cytochrome-p450-inhibition.html
Cytochrome P450 Inhibition Currently under Redevelopment Because of the important role of Cytochrome p450 enzymes in drug metabolism, it is important to assess the ability of lead compounds to inhibit specific cytochrome p450 enzymes to avoid potential drug-drug interactions where one drug may affect the metabolism of another. This assay is only recommended for advanced leads. Typical Assay Conditions Isoform Source Substrate Positive Inhibitor 1A2 BD Bioscience Supersome phenacetin furfylline
2021 Publications: Preclinical Pharmacology Core - UT Southwestern
https://www.utsouthwestern.edu/research/core-facilities/preclinical-pharmacology/publications/2021-publications.html
2021 Publications Li J, Canseco D, Wang Y, Vale G, Chaudhary J, Anwar A, Baniasadi H, Williams NS , Gopal P, Sutphin PD, McDonald JG, Putnam WC, Corbin IR. Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver. Eur J Pharm Biopharm . 2021 Jan;158:273-283. PMCID: PMC8121338. Marcyk PT, LeBlanc EV, Kuntz DA, Xue A, Ortiz F , Trilles R, Bengtson S, Kenney TMG, Huang DS, Robbins N, Williams NS , Krysan DJ, Privé GG